Fluorouracil (Compound)

Synonyms:5-Fluorouracil, fluorouracil, 51-21-8, 5-FU, Fluoroplex, Efudex, Adrucil, Carac, Fluracil, 5-fluoropyrimidine-2,4(1H,3H)-dione, Fluoroblastin, Queroplex, Kecimeton, Phthoruracil, Carzonal, Timazin, Arumel, Efudix, Fluril, 5-Fluoracil, Fluracilum, Ulup, 5-fluoro-1H-pyrimidine-2,4-dione, Fluorouracilum, Fluro Uracil, 5 Fluorouracil, 5-Fluoruracil, Ftoruracil, Efurix, Fluri, 5-Fluoro-2,4(1H,3H)-pyrimidinedione, 5-Fluoropyrimidine-2,4-dione, Effluderm (free base), Fluorouracilo, 2,4(1H,3H)-Pyrimidinedione, 5-fluoro-, 2,4-Dihydroxy-5-fluoropyrimidine, Ro 2-9757, Uracil, 5-fluoro-, 5-fluoropyrimidine-2,4-diol, 5-Fluor-2,4-pyrimidindiol, 5-fluoro uracil, 5-fluoro-uracil, 5-Ftouracyl, 2,4-Dioxo-5-fluoropyrimidine, NSC 19893, NSC-19893, Fluorouracil, 5-, 5-Fluoro-2,4-pyrimidinedione, Fluorouricil, Ro-2-9757, Tolak, 5-Fluor-2,4-dihydroxypyrimidin, U-8953, 5-Fluorouracil-6-d1, 191047-65-1, FU, CHEMBL185, 2,4-Pyrimidinediol, 5-fluoro- (9CI), MLS000069498, 5 FU, 5FU, Fluroblastin, Phtoruracil, DTXSID2020634, CHEBI:46345, Fluoro-uracile, Fluoro-uracilo, U3P01618RT, NSC19893, 5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione, 5-Faracil, Cinco FU, Ro-29757, 191047-64-0, 191115-88-5, URF, NCGC00015442-02, Fluorouracile, Effluderm, SMR000038082, Fluorouracile [DCIT], 5-Fluoracil [German], 5-Fluoracyl, 5-Fluoruracil [German], 1004-03-1, DTXCID40634, Fluorouracilum [INN-Latin], Fluorouracilo [INN-Spanish], 5-Fluoropyrimidin-2,4-diol, Fluorouracil (Adrucil), Fluorouracil Cream, CAS-51-21-8, Fluoroplex (TN), 5-Fluor-2,4-pyrimidindiol [Czech], Adrucil (TN), CCRIS 2582, Carac (TN), 5-Fluor-2,4-dihydroxypyrimidin [Czech], HSDB 3228, SR-01000075881, 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech], EINECS 200-085-6, 5-Fluor-2,4(1H,3H)-pyrimidindion, Fluouracil, inhibits thymilidate synthetase, UNII-U3P01618RT, 2,4-Dioxo-5-fluoropryimidine, 5-fluorourasil, AI3-25297, Fluoro Uracil, 5-florouracil, 5-fluorouacil, 5-FU (TN), 5-Fluracil, 1upf, 5F-uracil, U 8953, 1-fluoro-1h-pyrimidine-2,4-dione, Adrucil (ICN), MFCD00006018, Adrucil (Fluorouracil), Fluorouracil - Adrucil, Fluorouracil [USAN:USP:INN:BAN:JAN], Spectrum_000841, Opera_ID_134, 5-Fluorouracil, 99%, Spectrum2_000076, Spectrum3_000434, Spectrum4_000557, Spectrum5_000718, WLN: T6MVMVJ EF, FLUOROURACIL [MI], Lopac-F-6627, F0151, FLUOROURACIL [INN], FLUOROURACIL [JAN], UPCMLD-DP130, EC 200-085-6, F 6627, FLUOROURACIL [HSDB], FLUOROURACIL [USAN], SCHEMBL3646, 5-fluorpyrimidin-2,4-diol, FLUOROURACIL [VANDF], Folfox component fluorouracil, Lopac0_000536, BSPBio_002048, FLUOROURACIL [MART.], KBioGR_001253, KBioSS_001321, 2(1H)-Pyrimidinone, 5-fluoro-4-hydroxy- (9CI), 4(3H)-Pyrimidinone, 5-fluoro-2-hydroxy- (9CI), MLS002415705, DivK1c_000054, FLUOROURACIL [USP-RS], FLUOROURACIL [WHO-DD], FLUOROURACIL [WHO-IP], SPECTRUM1500305, SPBio_000291, 5-FLUOROURACIL [IARC], 5-fluoro-2,4-dioxo-pyrimidin, 5-fluoro-pyrimidine-2,4-diol, GTPL4789, UPCMLD-DP130:001, Fluorouracil (JP17/USP/INN), HMS500C16, KBio1_000054, KBio2_001321, KBio2_003889, KBio2_006457, KBio3_001268, 5-Fluoro-2,3H)-pyrimidinedione, 5-FLUOROURACIL [WHO-IP], 2,4-Pyrimidinedione, 5-fluoro-, NINDS_000054, BCPP000428, FLUOROURACIL [ORANGE BOOK], HMS1920O18, HMS2090I04, HMS2091F19, HMS3259O03, HMS3261L13, HMS3654K22, HMS3715H03, HMS3865L03, Pharmakon1600-01500305, FLUOROURACIL [EP MONOGRAPH], 5-Fluorouracil, analytical standard, BCP02083, 2,3H)-Pyrimidinedione, 5-fluoro-, Fluorouracil (5-Fluoracil, 5-FU), Fluorouracil (5-Fluoracil; 5-FU), FLUOROURACIL [USP MONOGRAPH], Tox21_110150, Tox21_202335, Tox21_300112, Tox21_500536, BDBM50340677, CCG-39879, DL-399, NSC757036, NSC816997, s1209, STK297802, STL367375, FLUOROURACILUM [WHO-IP LATIN], AKOS000119162, AKOS003237897, AKOS008044307, Tox21_110150_1, BCP9000239, CS-0993, DB00544, KS-5129, LP00536, NC00454, NSC-757036, NSC-816997, SDCCGSBI-0050519.P005, FLUCYTOSINE IMPURITY A [WHO-IP], IDI1_000054, NCGC00015442-01, NCGC00015442-03, NCGC00015442-04, NCGC00015442-05, NCGC00015442-06, NCGC00015442-07, NCGC00015442-08, NCGC00015442-09, NCGC00015442-10, NCGC00015442-11, NCGC00015442-12, NCGC00015442-15, NCGC00015442-16, NCGC00015442-24, NCGC00015442-30, NCGC00091349-01, NCGC00091349-02, NCGC00091349-03, NCGC00091349-04, NCGC00091349-05, NCGC00091349-07, NCGC00091349-08, NCGC00254023-01, NCGC00259884-01, NCGC00261221-01, 5-Fluoro-2,4-(1H,3H)-pyrimidinedione, AC-11201, BF166014, EMTRICITABINE IMPURITY F [WHO-IP], HY-90006, NCI60_001652, SRI-10792-04, SRI-10792-05, SRI-10792-06, SRI-10792_07, SRI-10792_08, 5-Fluoro-1H-pyrimidine-2,4-dione(5FU), 5-Fluorouracil, >=99% (HPLC), powder, SBI-0050519.P004, 5-Fluoro-1H-pyrimidine-2,4-dione(5-FU), DB-051923, DB-065735, 5-Fluoro-1H-pyrimidine-2,4-dione (5-FU), A7567, AM20100252, EU-0100536, FLUCYTOSINE IMPURITY A [EP IMPURITY], FT-0601511, FT-0668745, FT-0695666, FT-0695667, FT-0707652, SW199617-3, 5-Fluoro-1H-pyrimidine-2,4-dione(5-FUra), EN300-33909, Fluorouracil, meets USP testing specifications, C07649, D00584, 5-Fluorouracil, Vetec(TM) reagent grade, >=99%, Q238512, W-60379, (5-fluorouracil)5-Fluoro-1H-pyrimidine-2,4-dione, 5-Fluoro-1H-pyrimidine-2,4-dione(5-fluoro uracil), SR-01000075881-1, SR-01000075881-3, SR-01000075881-5, W-202929, 5-Fluoro-1H-pyrimidine-2,4-dione (5-Fluorouracil), BRD-K24844714-001-02-1, 5-FLUOROPYRIMIDIN-2,4(1H,3H)-DIONE [WHO-IP], Z275128052, 5-Fluoro-1H-pyrimidine-2,4-dione(5-fluorouracil)(5-FU), 5-Fluorouracil, certified reference material, TraceCERT(R), Fluorouracil, British Pharmacopoeia (BP) Reference Standard, Fluorouracil, European Pharmacopoeia (EP) Reference Standard, Fluorouracil, United States Pharmacopeia (USP) Reference Standard, pyrimidine antimetabolite: inhibits nucleic acid replication; tetratogen, Fluorouracil, Pharmaceutical Secondary Standard; Certified Reference Material

Pubchem:PUBCHEM:3385

Id:fe2d38a4-ac73-57f3-b969-a1f36d2c23ab

Description:nan